Atara Biotherapeutics Inc. (ATRA) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Atara Biotherapeutics Inc., updated every trading day.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances)
Atara Biotherapeutics Inc. (ATRA) is a Health Care company in Biotechnology: Biological Products (No Diagnostic Substances), worth $83M. It trades at $8.66, up 4.34% today. Its overall quality score is 39 out of 100, ranked against the whole US market. 2 analysts' average target of $15.50 implies +79.0% from today's price. Kronos AI's 30-day forecast is +21.0% (8 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $15.50 |
| Low – high | $13.00 – $18.00 |
| Analysts | 2 |
| Upside to average | +79.0% |
Kronos AI 30-day forecast
| Expected close | $10.04 (+21.0%) |
| Likely range | +8.1% … +29.7% |
| As of | 2026-10-27 |
Quality scores
| Profitability | 21 |
| Solvency | 39 |
| Growth | 56 |
| Overall | 39 |
| P/E | — |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Halal Health Care stocks · Zakat calculator · Purification calculator